Intuitive Surgical, Inc. $ISRG Position Boosted by Principal Financial Group Inc.

Principal Financial Group Inc. lifted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 11.8% during the 1st quarter, HoldingsChannel.com reports. The firm owned 615,749 shares of the medical equipment provider’s stock after acquiring an additional 64,877 shares during the quarter. Principal Financial Group Inc.’s holdings in Intuitive Surgical were worth $283,854,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Riversedge Advisors LLC lifted its stake in Intuitive Surgical by 1.9% during the fourth quarter. Riversedge Advisors LLC now owns 901 shares of the medical equipment provider’s stock valued at $510,000 after purchasing an additional 17 shares during the last quarter. Fiduciary Financial Group LLC grew its position in Intuitive Surgical by 2.1% in the fourth quarter. Fiduciary Financial Group LLC now owns 920 shares of the medical equipment provider’s stock worth $521,000 after buying an additional 19 shares during the last quarter. Prosperity Consulting Group LLC grew its position in Intuitive Surgical by 0.5% in the third quarter. Prosperity Consulting Group LLC now owns 4,033 shares of the medical equipment provider’s stock worth $1,804,000 after buying an additional 19 shares during the last quarter. Sunburst Financial Group LLC increased its holdings in shares of Intuitive Surgical by 4.3% in the fourth quarter. Sunburst Financial Group LLC now owns 485 shares of the medical equipment provider’s stock valued at $275,000 after buying an additional 20 shares in the last quarter. Finally, WoodTrust Financial Corp increased its holdings in shares of Intuitive Surgical by 0.5% in the fourth quarter. WoodTrust Financial Corp now owns 4,180 shares of the medical equipment provider’s stock valued at $2,367,000 after buying an additional 20 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of brokerages have recently commented on ISRG. Robert W. Baird increased their price objective on Intuitive Surgical from $575.00 to $610.00 and gave the company an “outperform” rating in a research report on Wednesday, April 22nd. JPMorgan Chase & Co. decreased their target price on Intuitive Surgical from $625.00 to $550.00 and set an “overweight” rating on the stock in a report on Wednesday, April 22nd. Leerink Partners cut their target price on Intuitive Surgical from $622.00 to $573.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 22nd. Royal Bank Of Canada reduced their target price on Intuitive Surgical from $650.00 to $600.00 and set an “outperform” rating for the company in a report on Monday. Finally, TD Cowen decreased their price target on Intuitive Surgical from $585.00 to $520.00 and set a “buy” rating for the company in a research report on Monday. One analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average target price of $566.27.

Intuitive Surgical Stock Down 6.8%

ISRG opened at $379.50 on Wednesday. The firm has a market capitalization of $134.40 billion, a P/E ratio of 46.00, a PEG ratio of 3.31 and a beta of 1.46. The stock has a fifty day moving average of $419.65 and a 200-day moving average of $471.31. Intuitive Surgical, Inc. has a 12-month low of $378.50 and a 12-month high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, beating analysts’ consensus estimates of $2.08 by $0.42. The business had revenue of $2.77 billion for the quarter, compared to the consensus estimate of $2.62 billion. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.Intuitive Surgical’s revenue for the quarter was up 23.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.81 earnings per share. On average, analysts expect that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current fiscal year.

Intuitive Surgical News Roundup

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Analysts and market watchers still point to solid underlying business momentum, including strong da Vinci procedure growth, continued da Vinci 5 adoption, and expectations that Intuitive Surgical could beat Q2 earnings estimates. Article Title
• Positive Sentiment: Some commentary says the recent weakness reflects investor sentiment and valuation concerns more than company fundamentals, suggesting the long-term growth story remains intact. Article Title
• Neutral Sentiment: The company is heading into its July 16 earnings report, which is keeping traders on the sidelines and increasing volatility ahead of the release. Article Title
• Negative Sentiment: Fresh analyst price-target cuts, including TD Cowen’s reduction to $520 from $585, have reinforced concerns about valuation, competition, international-market challenges, and tariff pressure on margins. Article Title
• Negative Sentiment: The stock also saw unusually heavy put buying and a broader pullback in medtech names, signaling that some investors are positioning defensively ahead of earnings. Article Title

Insiders Place Their Bets

In other news, SVP Iman Jeddi sold 5,625 shares of the company’s stock in a transaction dated Monday, June 1st. The stock was sold at an average price of $420.55, for a total value of $2,365,593.75. Following the transaction, the senior vice president owned 6,463 shares in the company, valued at $2,718,014.65. This represents a 46.53% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the stock in a transaction that occurred on Wednesday, June 10th. The stock was sold at an average price of $424.14, for a total transaction of $169,656.00. Following the completion of the sale, the executive vice president directly owned 5,720 shares of the company’s stock, valued at $2,426,080.80. This trade represents a 6.54% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 7,169 shares of company stock worth $3,059,135. 0.60% of the stock is currently owned by company insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.